![]() |
RELATED RESOURCES |
SEC Filings:SYRSSYROS PHARMACEUTICALS INC0.8914
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2021 | Form 8-K* | Current Report* | 01/20/2021 | 01/19/2021 |
Form EFFECT | Notice of Effectiveness | 01/19/2021 | N/A | |
Form 424B5 | Prospectus | 01/19/2021 | N/A | |
Form 8-K* | Current Report* | 01/19/2021 | 01/19/2021 | |
Form 8-K* | Current Report* | 01/11/2021 | 01/08/2021 | |
2020 | Form 8-K* | Current Report* | 12/23/2020 | 12/23/2020 |
Form 4 | Insider Transaction | 12/21/2020 | 12/18/2020 | |
2016 | Form 4/A | Insider Transaction | 12/21/2020 | 09/27/2016 |
2020 | Form SC 13G | Beneficial Ownership Statement | 12/18/2020 | N/A |
Form D | Notice of Exempt Offering of Securities | 12/17/2020 | N/A | |
Form SC 13G | Beneficial Ownership Statement | 12/14/2020 | N/A | |
Form 4 | Insider Transaction | 12/11/2020 | 12/08/2020 | |
Form 8-K* | Current Report* | 12/08/2020 | 12/08/2020 | |
Form 8-K* | Current Report* | 12/07/2020 | 12/04/2020 | |
Form 4 | Insider Transaction | 11/18/2020 | 11/16/2020 |